Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 28 February, 2024|Author: Getaka | Social: X Twitter Profile

Fundamental Analysis of Sun Pharma Advanced Research Company Ltd

About the Company - Sun Pharma Advanced Research Company Ltd

Sun Pharma Advanced Research Company Ltd. is a Public Limited Listed company incorporated on 01/03/2006 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L73100GJ2006PLC047837 and registration number is 047837. Currently Company is involved in the business activities of Research and experimental development on natural sciences and engineering. Company’s Total Operating Revenue is Rs. 137.25 Cr. and Equity Capital is Rs. 27.19 Cr. for the Year ended 31/03/2022.
INDUSTRYADDRESSCONTACT
MiscellaneousPlot No. 5 & 6/1, Savli G.I.D.C. Estate, Vadodra District Gujarat 391775secretarial@sparcmail.com
http://www.sparc.life
Management
NamePosition Held
Mr. Dilip S ShanghviChairman & Non-Exe.Director
Dr. T RajamannarNon Executive Director
Dr. Robert J SpiegelIndependent Director
Mr. Sudhir V ValiaNon Executive Director
Ms. Bhavna DoshiIndependent Director
Dr. Ferzaan EngineerIndependent Director

Sun Pharma Advanced Research Company Ltd. Share Price Update

Share PriceValue
Today₹359.00
Previous Day₹356.00

Basic Stock Data of Sun Pharma Advanced Research Company Ltd

Market Cap 11,212 Cr.
Current Price 346
High / Low424/160
Stock P/E
Book Value 10.2
Dividend Yield0.00 %
ROCE106 %
ROE144 %
Face Value 1.00

Data Source: screener.in

Competitors of Sun Pharma Advanced Research Company Ltd

Stock NameMarket CapCurrent PriceHigh / LowStock P/EBook ValueDividend YieldROCEROEFace Value
Vasa Retail and Overseas Ltd (VASA) 4.02 Cr. 6.7018.5/5.35 29.50.00 %117 %% 10.0
Add-Shop E-Retail Ltd 81.0 Cr. 28.645.0/28.16.45 40.40.00 %38.0 %26.4 % 10.0
Syngene International Ltd 29,442 Cr. 732860/56357.9 96.80.07 %14.5 %13.4 % 10.0
Industry Average9,842.34 Cr255.7721.4555.570.02%56.50%13.27%10.00

Sun Pharma Advanced Research Company Ltd Quarterly Results

MonthDec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
Sales222822286225283213148242114
Expenses85787683739210794115137126113116
Operating Profit-63-50-54-55-11-67-78-6316-90-102-91-103
OPM %-289%-180%-245%-196%-18%-264%-275%-198%12%-188%-427%-432%-740%
Other Income200500000111086
Interest4453222330000
Depreciation3333333333333
Profit before tax-68-57-61-55-16-71-82-6810-82-95-86-100
Tax %0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Profit-68-57-61-55-16-71-82-6810-82-95-86-100
EPS in Rs-2.58-2.16-2.34-2.09-0.60-2.61-3.03-2.520.37-2.53-2.94-2.66-3.07

Sun Pharma Advanced Research Company Ltd Quarterly Chart

Sun Pharma Advanced Research Company Ltd Profit & Loss

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Sales29871671561611817818377253137239224
Expenses99104134191224304321334387388324453491
Operating Profit-70-1734-35-63-123-243-151-310-135-187-214-267
OPM %-241%-19%20%-23%-39%-68%-310%-83%-404%-53%-136%-90%-119%
Other Income12103314541410571129
Interest046022003111384
Depreciation33478888911101212
Profit before tax-72-2234-40-70-119-197-145-312-151-203-223-254
Tax %0%0%12%0%0%0%0%0%0%0%0%0%
Net Profit-72-2230-40-70-119-197-145-312-151-203-223-254
EPS in Rs-2.93-0.911.23-1.60-2.83-4.82-7.85-5.55-11.92-5.77-7.48-6.86-7.76
Dividend Payout %0%0%0%0%0%0%0%0%0%0%0%0%

Sun Pharma Advanced Research Company Ltd Profit & Loss Yearly Chart

Add-Shop E-Retail Ltd Growth

Compounded Sales Growth
10 Years:11%
5 Years:25%
3 Years:46%
TTM:-51%
Compounded Profit Growth
10 Years:%
5 Years:2%
3 Years:9%
TTM:-72%
Stock Price CAGR
10 Years:8%
5 Years:17%
3 Years:28%
1 Year:89%
Return on Equity
10 Years:%
5 Years:%
3 Years:%
Last Year:-144%

Sun Pharma Advanced Research Company Ltd Balance Sheet

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Sep 2023
Equity Capital21242424242525262626273232
Reserves-8785116768133160270-45-194-230480299
Borrowings6881545632267236791614
Other Liabilities8420393975111122101224162404302322
Total Liabilities86209184143163273309398273230280830667
Fixed Assets64666467706952581049192106132
CWIP10101132432526272
Investments097600101082118612291151
Other Assets21461127692192146106128127150406382
Total Assets86209184143163273309398273230280830667

Sun Pharma Advanced Research Company Ltd Reserves and Borrowings Chart

Add-Shop E-Retail Ltd Cash Flow

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Cash from Operating Activity -69-9537-41-44-128-183-172-211-152-208-69
Cash from Investing Activity -2-994453-13-7-105-1021552-29-548
Cash from Financing Activity 72194-81-15119422427455159229617
Net Cash Flow0-0-011-760-63009-8-1

Sun Pharma Advanced Research Company Ltd Financial Efficiency Indicators

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Debtor Days5410561472178822076257450
Inventory Days-0-0-0-0-0-0-0-0-0-0-0
Days Payable
Cash Conversion Cycle5410561472178822076257450
Working Capital Days-8997212921-42-59-232-98-557-96-97-189
ROCE %-1,034%-20%21%-32%-71%-94%-143%-62%-183%-242%-106%

Sun Pharma Advanced Research Company Ltd Financial Efficiency Indicators Chart

Sun Pharma Advanced Research Company Ltd Share Holding Pattern

MonthMar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
Promoters68.46%68.46%68.10%68.10%69.09%69.09%69.09%68.23%65.68%65.68%65.68%65.68%
FIIs2.69%2.61%2.54%2.51%2.38%2.40%2.38%3.48%3.64%3.64%3.67%3.30%
DIIs0.02%0.02%0.56%0.55%0.76%0.76%0.76%0.76%0.63%0.63%0.65%0.67%
Public28.83%28.91%28.81%28.84%27.77%27.75%27.77%27.53%30.04%30.06%29.99%30.36%
No. of Shareholders99,4541,10,30194,83495,03992,73694,49493,71896,33798,7771,00,8071,01,4331,03,990

Sun Pharma Advanced Research Company Ltd Shareholding Pattern Chart

No. of Sun Pharma Advanced Research Company Ltd Shareholders

Sun Pharma Advanced Research Company Ltd Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)
Quant Small Cap Fund5958690.1317.09
ITI Pharma and Healthcare Fund586281.171.68
Nippon India Nifty Smallcap 250 Index Fund485280.141.39
Motilal Oswal Nifty Smallcap 250 Index Fund303260.140.87
SBI Nifty Smallcap 250 Index Fund238050.140.68
ICICI Prudential Nifty Smallcap 250 Index Fund113300.140.32
HDFC NIFTY Smallcap 250 ETF65730.140.19
HDFC Nifty Smallcap 250 Index Fund53010.140.15
Motilal Oswal Nifty 500 Index Fund30600.010.09
Edelweiss Nifty Smallcap 250 Index Fund12340.140.04

Sun Pharma Advanced Research Company Ltd ROCE Trend

Sun Pharma Advanced Research Company Ltd EPS Trend

Sun Pharma Advanced Research Company Ltd Key Financial Ratios

MonthMar 23Mar 22Mar 21Mar 20Mar 19
FaceValue1.001.001.001.001.00
Basic EPS (Rs.)-7.82-7.73-5.77-11.92-5.69
Diluted EPS (Rs.)-7.827.73-5.77-11.92-5.69
Cash EPS (Rs.)-6.50-7.11-5.35-11.56-5.49
Book Value[Excl.RevalReserv]/Share (Rs.)15.801.15-6.42-0.7111.80
Book Value[Incl.RevalReserv]/Share (Rs.)15.801.15-6.42-0.7111.80
Revenue From Operations / Share (Rs.)7.365.059.652.937.29
PBDIT / Share (Rs.)-6.26-6.62-4.94-11.46-5.49
PBIT / Share (Rs.)-6.62-6.99-5.36-11.82-5.79
PBT / Share (Rs.)-6.86-7.48-5.77-11.92-5.80
Net Profit / Share (Rs.)-6.86-7.48-5.77-11.92-5.80
PBDIT Margin (%)-85.09-131.07-51.22-390.87-75.34
PBIT Margin (%)-90.01-138.48-55.53-403.21-79.47
PBT Margin (%)-93.21-148.19-59.74-406.69-79.52
Net Profit Margin (%)-93.21-148.19-59.74-406.69-79.52
Return on Networth / Equity (%)-43.40-651.370.000.00-49.09
Return on Capital Employeed (%)-33.00-174.923836.49-832.42-47.89
Return On Assets (%)-26.81-72.61-65.80-114.61-36.49
Long Term Debt / Equity (X)0.000.00-0.69-0.340.00
Total Debt / Equity (X)0.002.40-1.17-3.640.00
Asset Turnover Ratio (%)0.430.531.010.220.51
Current Ratio (X)2.540.410.270.282.71
Quick Ratio (X)2.540.410.270.282.71
Interest Coverage Ratio (X)-26.61-13.50-12.17-112.25-1467.35
Interest Coverage Ratio (Post Tax) (X)-28.15-14.26-13.19-115.79-1547.78
Enterprise Value (Cr.)5712.178144.743900.742596.184818.56
EV / Net Operating Revenue (X)23.9259.3415.4233.8026.35
EV / EBITDA (X)-28.11-45.27-30.11-8.65-34.97
MarketCap / Net Operating Revenue (X)24.3958.8114.6832.9226.35
Price / BV (X)11.36258.49-22.07-135.6916.26
Price / Net Operating Revenue (X)24.3958.8114.6832.9226.35
EarningsYield-0.03-0.02-0.04-0.12-0.03

Sun Pharma Advanced Research Company Ltd Profitability Ratios (%)

Sun Pharma Advanced Research Company Ltd Liquidity Ratios

Sun Pharma Advanced Research Company Ltd Liquidity Ratios (%)

Sun Pharma Advanced Research Company Ltd Interest Coverage Ratios (X)

Sun Pharma Advanced Research Company Ltd Valuation Ratios

Fair Value / Intrinsic Value of Sun Pharma Advanced Research Company Ltd

Fair Value: ₹224.73

The stock is overvalued by 35.05% compared to the current price ₹346

*Investments are subject to market risks

Strength and Weakness of Sun Pharma Advanced Research Company Ltd

StrengthWeakness
  1. The stock has a low average Working Capital Days of -170.58, which is a positive sign.
  2. The company has higher reserves (82.38 cr) compared to borrowings (48.69 cr), indicating strong financial stability.
  1. The stock is trading at a high valuation with an average P/B ratio of -7.32 and average Dividend Yield of -157.47%.
  2. The stock has a low average ROCE of -77.75%, which may not be favorable.
  3. The stock has a high average Cash Conversion Cycle of 57.75, which may not be favorable.
  4. The company has not shown consistent growth in sales (151.69) and profit (-136.46).

Should I Buy Add-Shop E-Retail Ltd Share Now?

  • Considering various financial indicators, investors might exercise caution regarding investment in Sun Pharma Advanced Research Company Ltd:
    1. Net Profit Margin: -93.21%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: -33.00% (Industry Average ROCE: 79.17%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. Interest Coverage Ratio (Post Tax): -28.15
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    4. Quick Ratio: 2.54
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    5. ✓ Stock P/E of N/A (Industry average Stock P/E: 19.8)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    6. ✓ Total Debt / Equity: 0.00
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis suggests exercising caution. It's advisable to conduct further research or consult with financial experts before considering any investment.

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Sun Pharma Advanced Research Company Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE